Nuo Therapeutics, Inc. Quarterly Operating Income (Loss) in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Nuo Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q3 2024.
  • Nuo Therapeutics, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$577K, a 26.9% increase year-over-year.
  • Nuo Therapeutics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$2.48M, a 28.7% increase year-over-year.
  • Nuo Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$3.17M, a 4.59% increase from 2022.
  • Nuo Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$3.32M, a 3562% decline from 2021.
  • Nuo Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$90.7K, a 76% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$2.48M -$577K +$212K +26.9% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 -$2.69M -$542K +$329K +37.8% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 -$3.02M -$709K +$146K +17.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 -$3.17M -$652K +$311K +32.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-19
Q3 2023 -$3.48M -$790K +$122K +13.4% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 -$3.6M -$871K +$52.3K +5.66% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 -$3.65M -$855K -$333K -63.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 -$3.32M -$963K -$892K -1244% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-19
Q3 2022 -$2.43M -$912K -$905K -13407% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-20
Q2 2022 -$1.52M -$924K -$917K -14011% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$607K -$522K -$516K -9021% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$90.7K -$71.7K +$252K +77.9% Oct 1, 2021 Dec 31, 2021 10-K 2023-04-17
Q3 2021 -$343K -$6.75K -$497 -7.95% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-04
Q2 2021 -$342K -$6.55K -$753 -13% Apr 1, 2021 Jun 30, 2021 10-Q/A 2022-08-10
Q1 2021 -$341K -$5.72K +$36.7K +86.5% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 -$378K -$324K -$397K -539% Oct 1, 2020 Dec 31, 2020 10-K 2022-04-15
Q3 2020 $19.3K -$6.25K +$32.4K +83.8% Jul 1, 2020 Sep 30, 2020 10-Q 2022-11-04
Q2 2020 -$13.1K -$5.79K +$387K +98.5% Apr 1, 2020 Jun 30, 2020 10-K 2022-04-15
Q1 2020 -$400K -$42.4K +$569K +93.1% Jan 1, 2020 Mar 31, 2020 10-K 2022-04-15
Q4 2019 -$969K $73.8K -$83.7K -53.2% Oct 1, 2019 Dec 31, 2019 10-K 2022-04-15
Q3 2019 -$885K -$38.7K +$373K +90.6% Jul 1, 2019 Sep 30, 2019 10-Q 2020-01-31
Q2 2019 -$1.26M -$392K +$190K +32.6% Apr 1, 2019 Jun 30, 2019 10-Q 2019-08-19
Q1 2019 -$1.45M -$612K +$55.9K +8.37% Jan 1, 2019 Mar 31, 2019 10-Q 2019-05-20
Q4 2018 -$1.5M $157K +$8.72M Oct 1, 2018 Dec 31, 2018 10-K 2019-04-16
Q3 2018 -$10.2M -$412K +$963K +70.1% Jul 1, 2018 Sep 30, 2018 10-Q 2020-01-31
Q2 2018 -$11.2M -$583K +$3.33M +85.1% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-19
Q1 2018 -$14.5M -$668K +$1.02M +60.4% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-20
Q4 2017 -$15.5M -$8.56M Oct 1, 2017 Dec 31, 2017 10-K 2019-04-16
Q3 2017 -$1.38M +$481K +25.9% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-16
Q2 2017 -$3.91M -$2.81M -254% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-13
Q1 2017 -$1.68M +$289K +14.6% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-14
Q3 2016 -$11.2M -$1.86M +$25.4M +93.2% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-13
Q2 2016 -$36.6M -$1.11M +$3.33M +75.1% May 5, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 -$39.9M -$1.97M +$1.4M +41.4% Jan 1, 2016 Mar 31, 2016 10-Q 2016-10-24
Q4 2015 -$41.3M -$6.25M -$1.83M -41.4% Oct 1, 2015 Dec 31, 2015 10-K 2016-10-24
Q3 2015 -$39.5M -$27.3M -$22.8M -506% Jul 1, 2015 Sep 30, 2015 10-Q 2015-11-13
Q2 2015 -$16.7M -$4.44M +$5.39M +54.8% Apr 1, 2015 Jun 30, 2015 10-Q 2015-08-13
Q1 2015 -$22.1M -$3.37M +$1.28M +27.5% Jan 1, 2015 Mar 31, 2015 10-Q 2016-10-24
Q4 2014 -$23.4M -$4.42M -$600K -15.7% Oct 1, 2014 Dec 31, 2014 10-K 2016-10-24
Q3 2014 -$22.8M -$4.5M +$112K +2.44% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-13
Q2 2014 -$22.9M -$9.82M -$5.16M -111% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-13
Q1 2014 -$17.7M -$4.65M +$353K +7.06% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-14
Q4 2013 -$18.1M -$3.82M -$202K -5.58% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-31
Q3 2013 -$17.9M -$4.61M -$401K -9.54% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-13
Q2 2013 -$17.5M -$4.66M -$2.31M -98.5% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-14
Q1 2013 -$15.2M -$5M -$2.28M -84% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-15
Q4 2012 -$12.9M -$3.62M -$3.86M -1617% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-31
Q3 2012 -$9.04M -$4.21M -$3.18M -308% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-12
Q2 2012 -$5.86M -$2.35M -$1.11M -89.7% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-08
Q1 2012 -$4.75M -$2.72M -$1.24M -83.4% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-09
Q4 2011 -$3.51M $239K Oct 1, 2011 Dec 31, 2011 10-K 2013-03-18
Q3 2011 -$1.03M +$259K +20.1% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-14
Q2 2011 -$1.24M +$322K +20.6% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-14
Q1 2011 -$1.48M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-15
Q3 2010 -$1.29M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-14
Q2 2010 -$1.56M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.